Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma

• Váldodahkkit: Li Li (Dahkki), Weiwei Zhang (Dahkki), Jinxin Qiu (Dahkki), Weiling Zhang (Dahkki), Mengmeng Lu (Dahkki), Jiaqian Wang (Dahkki), Yunfeng Jin (Dahkki), Qinghua Xi (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Hindawi Limited, 2023-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Ovarian serous cystadenocarcinoma (OV) is a fatal gynecologic cancer with a five-year survival rate of only 46%. Resistance to platinum-based chemotherapy is a prevalent factor in OV patients, leading to increased mortality. The platinum resistance in OV is driven by transcriptome heterogeneity and...